Pancreatic cancer is a disease in which cells in the pancreas grow abnormally, escape normal control, and may form a tumor. The pancreas is a deep abdominal organ involved in digestion and blood-sugar regulation, which is one reason pancreatic cancer can affect digestion, weight, appetite, bile flow, and diabetes-related changes.
Pancreatic cancer describes malignant tumors that begin in pancreatic tissue. These tumors may arise from cells involved in digestive enzyme production or, less commonly, from hormone-producing pancreatic endocrine cells.
Pancreatic cancer occurs when pancreatic cells acquire molecular changes that allow uncontrolled growth, survival, invasion, and possible spread. The most common form is pancreatic ductal adenocarcinoma, which is usually grouped with exocrine pancreatic cancers.
The pancreas helps digest food by producing enzymes and helps regulate blood sugar by producing hormones such as insulin and glucagon.
The pancreas sits deep in the abdomen, behind the stomach, so early tumors may not cause obvious symptoms.
Most pancreatic cancers are exocrine cancers, especially pancreatic ductal adenocarcinoma.
These quick facts help visitors understand pancreatic cancer while supporting search visibility for important educational terms.
This is the major type discussed in pancreatic cancer education and research.
Yellowing of the skin or eyes, dark urine, pale stools, appetite loss, and weight loss are important symptoms to recognize.
Pancreatic tumor biology often studies growth pathways, DNA repair, stromal tissue, immune evasion, and treatment resistance.
Pancreatic cancer is not one single disease. The main distinction is between exocrine pancreatic cancers and pancreatic neuroendocrine tumors.
The most common type. It usually starts in duct-like exocrine cells that are part of the digestive-enzyme drainage system.
Less common exocrine pancreatic tumors include acinar cell carcinoma and other rare histologic subtypes.
These tumors begin in hormone-producing endocrine cells and may behave very differently from pancreatic adenocarcinoma.
Some pancreatic cystic lesions may need monitoring or evaluation because a subset can have cancer potential.
Pancreatic cancer symptoms can be vague at first. Symptoms may relate to bile duct blockage, digestive enzyme changes, weight loss, pain, or blood-sugar changes.
Yellowing of the skin or eyes may occur when a tumor blocks bile flow.
Pain may occur in the upper abdomen and sometimes radiate toward the back.
Weight loss can relate to appetite changes, digestion problems, inflammation, or cancer metabolism.
Pale stools, greasy stools, dark urine, nausea, appetite loss, or indigestion can occur.
Pancreatic cancer biology includes genetic driver changes, dense stromal tissue, inflammation, immune escape, metabolic stress, invasion, metastasis, and treatment resistance.
KRAS is one of the most studied pancreatic cancer driver pathways and is linked with abnormal growth signaling.
BRCA-related and other inherited DNA repair changes may be relevant in some pancreatic cancer research and risk contexts.
Pancreatic tumors often contain abundant stromal tissue, fibroblasts, matrix, immune cells, and inflammatory signals.
Tumors can affect digestion, nutrition, pancreatic enzymes, blood sugar, and body weight.
Having a risk factor does not mean someone will develop pancreatic cancer. Many pancreatic cancer cases occur without an obvious single cause.
Smoking is one of the most consistently discussed modifiable risk factors.
Diabetes can be associated with pancreatic cancer risk and may also appear as a symptom pattern.
Long-term inflammation of the pancreas is a recognized risk context.
A family history of pancreatic cancer may increase risk and may lead to genetic-risk discussion.
BRCA-related syndromes, Lynch syndrome, and other inherited syndromes can be relevant.
Risk increases with age, and obesity is commonly discussed as a risk factor.
These short explanations support search intent, voice search, educational snippets, and clear indexing.
Most pancreatic cancers start in exocrine duct-like cells of the pancreas. Less common tumors start in hormone-producing endocrine cells.
The pancreas is deep in the abdomen and early symptoms can be vague, such as indigestion, appetite loss, fatigue, or mild abdominal discomfort.
Pancreatic adenocarcinoma is the most common pancreatic cancer type and is usually grouped with exocrine pancreatic cancers.
Pancreatic cancer is cancer that begins in the pancreas, an organ that helps digest food and regulate blood sugar.
Pancreatic cancer is a disease where cells in the pancreas grow abnormally, form a tumor, and may invade nearby tissue or spread to other parts of the body.
The most common type is pancreatic ductal adenocarcinoma, an exocrine pancreatic cancer.
Symptoms can include jaundice, abdominal or back pain, weight loss, appetite loss, digestive changes, dark urine, pale stools, fatigue, and diabetes-related changes.
Clear answers to common pancreatic cancer questions.
Pancreatic cancer is cancer that starts in the pancreas, a deep abdominal organ involved in digestion and blood-sugar regulation.
Pancreatic adenocarcinoma is the most common form of pancreatic cancer and usually begins in exocrine duct-like cells.
Commonly discussed symptoms include jaundice, abdominal or back pain, weight loss, appetite loss, digestive changes, dark urine, pale stools, fatigue, and diabetes-related changes.
Risk factors include smoking, type 2 diabetes, chronic pancreatitis, family history, inherited syndromes, obesity, older age, and heavy alcohol use.
No. This page is educational only and does not replace consultation with a qualified healthcare professional.
Authoritative sources used to support this pancreatic cancer education page.